Ontology highlight
ABSTRACT: Background
The analysis of liquid biopsies, e.g., circulating tumor cells (CTCs) is an appealing diagnostic concept for targeted therapy selection. In this proof-of-concept study, we aimed to perform multiparametric analyses of CTCs to select targeted therapies for metastatic breast cancer patients.Methods
First, CTCs of five metastatic breast cancer patients were analyzed by whole exome sequencing (WES). Based on the results, one patient was selected and monitored by longitudinal and multiparametric liquid biopsy analyses over more than three years, including WES, RNA profiling, and in vitro drug testing of CTCs.Results
Mutations addressable by targeted therapies were detected in all patients, including mutations that were not detected in biopsies of the primary tu
SUBMITTER: Franken A
PROVIDER: S-EPMC8657376 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature